1.03 - Inflammation Flashcards

1
Q

What is Inflammation?

A

Body’s response to injury
Part of the innate immune response
Limit and then repair damage cause by an injurious agent
It is primarily a protective response, which leads to repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the macroscopic signs of inflammation?

A
Redness
Swelling
Heat
Pain
Loss of Function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What occurs during the acute and chronic phases of inflammation?

A
Acute (Minutes, Hours, Days)
 - Leucocytes (mainly neutrophils)
 - Exudate of fluid and plasma proteins
Chronic (Weeks, Months, Years)
 - Lymphocytes and Macrophages
 - Proliferation of blood vessels, fibrosis, tissue necrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the components of inflammation?

A
Microvasculature
Circulating blood cells (red-passive, white-active)
Tissue cells (Secretion/release of mediators)
Inflammatory mediators (numerous)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the changes in the microvasculature that occur in inflammation?

A
  1. Transient vasocontriction (arterioles)
  2. Vasodilation of all vessels –> increase blood flow
  3. Permeability of small vessels increases –> exudate
  4. Blood flow becomes sluggish (stasis)
  5. Leucocytes become marginated and migrate in to extravascular space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is exudate?

A

exudate is any fluid that filters from the circulatory system into lesions or areas of inflammation.
Includes water, the dissolved solutes of blood, plasma proteins, white blood cells, platelets, and in the case of local vascular damage: red blood cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Inflammatory mediators

A

Products of circulating blood cells, local tissue and plasma proteins
End result of combined action is attraction of more leucocytes to the site of injury and facilitation of phagocytosis of injurious agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the plasma protein derived inflammatory mediators?

A

Complement system proteins

Coagulation, fibrinolytic and kinin system proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the cell and tissue derived inflammatory mediators?

A
Cytokines
Arachidonic acid metabolites
 - Prostaglandins
 - Leukotrienes
Histamine and other biogenic amines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 5 family groups of cytokines?

A
Interferons (IFN)
Interleukins (IL)
Chemokines
Colony Stimulating Factors
Growth Factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the functional groups classification for cytokines?

A

Proinflammatory (TNF, IL-1)
Anti-inflammatory (IL-10
Immunostimulatory (IL-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the cellular contributions to inflammation?

A
Polymorphs
Mast Cells
Monocytes & Macrophages
Platelets
Vascular Endothelial Cells
Neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the role of Polymorphs in inflammation

A

First to arrive

Engulf, kill (free radicals) and digest (enzymic) microbes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the role of Mast Cells in inflammation

A

When activated (such as by complement) they secrete mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the role of Monocytes & Macrophages in inflammation

A

Late arrivals
Secrete cytokines and chemokines
Engulf cell debris and microbes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the role of Platelets in inflammation

A

Prostaglandin/leukotriene synthesis
Free radicals
Pro-inflammatory

17
Q

Describe the role of Vascular Endothelial Cells in inflammation

A

Contract/relaxation (nitric oxide)

Also important in repair (angiogenesis)

18
Q

Describe the role of Neurons in inflammation

A

Release compounds including Substance P (pain) & Kinins

19
Q

What are the systemic sequelae of inflammation?

A

Increased temperature (Fever)
Increased blood leucocytes
Synthesis of plasma proteins
Symptoms and signs depend upon the total mass of inflammatory tissue
Site the inflammatory lesion is critical in giving rise to other symptoms and signs

20
Q

Is there a purpose behind a fever?

A

Many bacteria do not live or multiply as effectively in temperatures >38 degrees C. Therefore teleologically the “purpose” is protective and to aid clearance of infecting bacterial organisms.

21
Q

What different types of fever patterns are described? Are they useful diagnostically?

A

Many descriptive terms used. E.g. “spiking”, “nocturnal”, diurnal etc. Each gives the reader more information about “when”, “how long”, etc. The descriptions are useful clinically. E.g. in particular from of malaria, a high fever may occur every 3 to 4 days; this follows the lifecycle of that malarial parasite.

22
Q

What are some of the systemic sequelae of inflammation apart form fever?

A

Increased heart rate, increased pulse pressure, flushing, raised white cell count etc

23
Q

If you were designing pharmacological compounds to interfere with or minimise inflammation or its consequences, what sites could you target? Are there drugs which act at these sites now?

A

Decrease production of inflammatory compounds
- Decrease number of cells producing enzymes
- Immunosuppressants (Azathioprine)
- Glucocorticosteroids (Prednisolone)
- Decrease production of inflammatory cytokines
- NSAIDs (Aspirin/Paracetamol)
Decrease response to defined cytokines
- Antibodies to defined cytokines
- Anti-TNFalpha (infliximab)
- Decrease cellular response to cytokines by modification of nuclear response (mesalazine)

24
Q

Which “inflammatory” compounds cause pain? Do they act directly on receptors or via other mechanisms?

A

Some of inflammatory mediators cause pain directly by being agonists for specific receptors on pain fibres. Others “facilitate” or enhance this effect, also by acting at specific receptors on pain fibres, but in the absence of the inflammatory response, they them selves do not initiate the action potential which is subsequently “felt” as pain. See Chronic inflammation lecture.